Every time a new multitrillion-dollar IPO comes to market, my first thought is “when will we learn?”
While I’m no expert on artificial intelligence, I am quite tenured when it comes to retail investor mania about a stock offering. As well as investors’ willingness to step up each time and bail out a company that needs capital. Soon.
More Yield, Less Trap: Sign up free to get Barchart’s daily Dividend Investor newsletter straight to your inbox.
To me, the Anthropic (ANT) IPO is a necessary step along the lifecycle of the AI boom and bust. So, let’s get it over with.
Among the many angles of the forthcoming largest-ever IPO is the fact that an ETF already exists with a name that implies it already has exposure of some sort to Anthropic. Guess what? It doesn’t.
www.barchart.com The Anthropic AI Lab Ecosystem ETF (ANTW) launched in mid-August 2026 and has amassed around $27 million in assets. It provides exposure to companies within the Anthropic AI ecosystem.
Translation: Anthropic isn’t public (yet), so maybe you’ll pay 0.59% to own what essentially is the Invesco QQQ ETF (QQQ).
Same Schtick, Different ETF
Let’s be perfectly clear here. I DO NOT begrudge ANY ETF issuer from creating products. They have that right, and if the regulators bless it, who am I to stop the stampede of capitalism?
But I do believe strongly that the ETF complex has become, well, unnecessarily complex. Investors are constantly saying out loud something that simply is not true: they seem to interpret that there are thousands of different ETFs. My guess is that there are maybe 100 at most that cannot simply be explained by another existing, and probably more-tenured, fund product.
So, Wall Street’s product creation machine never sleeps. And whenever retail FOMO reaches a boiling point around an upcoming mega-IPO, ETF sponsors don’t wait for the company to ring the opening bell. They manufacture ETFs so investors can gamble on the hype right now.
ANTW’s pitch is persuasive, but looking under the hood reveals a fund whose actual trading behavior differs sharply from its marketing. Despite having no explicit daily leverage in its prospectus, ANTW doesn't trade like a diversified tech basket. It trades almost tick-for-tick like the ProShares Ultra QQQ ETF (QLD) – a leveraged version of QQQ – as shown below:
www.barchart.com What Are You Actually Buying?
When investors buy an ETF with “Anthropic” in the title, they often assume they are getting direct, pure-play exposure to the premier private AI lab behind Claude. Because Anthropic is not yet a publicly traded stock, the fund manager has to populate the portfolio with publicly available proxies.
A look at ANTW’s top 10 holdings (which make up a concentrated 57% of the entire fund) shows where the money actually sits. In order:
Alphabet (GOOGL) Terawulf (WULF) Amazon (AMZN) Microsoft (MSFT) Broadcom (AVGO) Salesforce (CRM) Riot Platforms (RIOT) Micron (MU) SpaceX (SPCX) Astera Labs (ALAB)The large-cap tech cornerstones are obvious: Amazon, Google, and Microsoft have committed billions to Anthropic in cloud compute partnerships. The rest of the roster, however, includes names like WULF and RIOT, which do give ANTW a slightly different flavor than QQQ. But as I contend often, in a rotten market, all fall down.
How to Approach It
There is nothing inherently wrong with trading high-beta technology if you understand the risks. The problem comes when an investor holding a conservative retirement portfolio buys an ETF with a tech lab’s name on it, thinking they’ve made a diversified, forward-looking investment.
Before buying the latest thematic ETF, look past the ticker symbol, look past the marketing deck, and examine the holdings. If it looks like Anthropic on the outside but trades like a leveraged QQQ on the inside, manage your risk accordingly.
Rob Isbitts is a semi-retired CIO, former fiduciary investment advisor, Barchart columnist, and straight-talker. Download his new free e-book on hedged bond investing for retirement at ETFYourself.com. His research and model portfolios are at ROAR.PiTrade.com.
On the date of publication, Rob Isbitts did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
This Analyst Just Upgraded Broadcom Stock. Here's Why. Dear SK hynix Stock Fans, Mark Your Calendars for October 28 Ahead of the Hotly Anticipated Anthropic IPO, This ETF Promises Access to the Claude Maker’s Ecosystem. Don’t Be Fooled Into Thinking You Get ANT Stock. Amazon Stock: Wall Street Says AMZN Looks Increasingly Attractive Ahead of Q3 Earnings